These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma. Kroschinsky F; Hölig K; Platzbecker U; Poppe-Thiede K; Ordemann R; Blechschmidt M; Oelschlaegel U; Schaich M; Hänel M; Bornhäuser M; Ehninger G Transfusion; 2006 Aug; 46(8):1417-23. PubMed ID: 16934080 [TBL] [Abstract][Full Text] [Related]
23. Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders. Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA Br J Haematol; 2008 Apr; 141(2):205-11. PubMed ID: 18318761 [TBL] [Abstract][Full Text] [Related]
24. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH; Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634 [TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis. Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348 [TBL] [Abstract][Full Text] [Related]
26. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968 [TBL] [Abstract][Full Text] [Related]
27. [Autologous peripheral blood stem cell transplantation for Japanese multiple myeloma patients: results of a feasibility study]. Nakamura Y; Sakamaki H; Mukai H; Kojima H; Tomiyama J; Mori S; Hiruma K; Nakamura N; Toyota S; Hamaguchi H; Dans K; Mitani K; Saito K Rinsho Ketsueki; 2004 Jul; 45(7):524-9. PubMed ID: 15359911 [TBL] [Abstract][Full Text] [Related]
28. Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients. Martino M; Console G; Callea V; Stelitano C; Massara E; Irrera G; Messina G; Morabito F; Iacopino P Eur J Haematol; 2007 Jan; 78(1):35-40. PubMed ID: 17042773 [TBL] [Abstract][Full Text] [Related]
29. Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss. Maclean PS; Parker AN; McQuaker IG; Clark AD; Farrell E; Douglas KW Bone Marrow Transplant; 2007 Oct; 40(7):665-9. PubMed ID: 17646841 [TBL] [Abstract][Full Text] [Related]
30. Thalidomide and dexamethasone in patients with multiple myeloma not undergoing upfront autologous stem cell transplantation. Blade J Haematologica; 2005 Dec; 90(12):1589. PubMed ID: 16330426 [No Abstract] [Full Text] [Related]
31. [Autologous stem cell transplantation in multiple myeloma - pro]. Goldschmidt H Dtsch Med Wochenschr; 2009 Sep; 134(39):1942. PubMed ID: 19760555 [No Abstract] [Full Text] [Related]
33. Autologous stem cell transplantation beyond 60 years of age. Jantunen E Bone Marrow Transplant; 2006 Dec; 38(11):715-20. PubMed ID: 17041609 [TBL] [Abstract][Full Text] [Related]
34. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation. Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021 [TBL] [Abstract][Full Text] [Related]
35. Role of stem cell transplantation. Harousseau JL Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593 [TBL] [Abstract][Full Text] [Related]
36. Autologous stem cell transplants in Jehovah's Witnesses. Brown NM; Kim SY; Ford PA Bone Marrow Transplant; 2009 Sep; 44(6):391-2. PubMed ID: 19308040 [No Abstract] [Full Text] [Related]
37. [The importance of autologous transplantation in multiple myeloma]. Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373 [TBL] [Abstract][Full Text] [Related]
38. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018 [TBL] [Abstract][Full Text] [Related]
39. Newly diagnosed multiple myeloma: allograft or autograft? Gupta D; Kumar L Natl Med J India; 2007; 20(6):300-1. PubMed ID: 18335797 [No Abstract] [Full Text] [Related]
40. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma. Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]